Publications & News

WilmerHale Counsels Karyopharm Therapeutics in Public Offering of Shares

May 8, 2018

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, has announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters' option to purchase additional shares. 

The WilmerHale team counseling Karyopharm was led by Jason Kropp and Steven Singer, and included Bruce Manheim, Kimberly Wethly, Jeffries Oliver-Li, Meghan Walsh, Brett Bromann and Michael Lopes.

Read Karyopharm's press release for more information.